Download PDF
Aktuelle Dermatologie 2010; 36(12): 467-470
DOI: 10.1055/s-0030-1255865
Übersicht

© Georg Thieme Verlag KG Stuttgart · New York

Alarmine und ihre Bedeutung für entzündliche Hauterkrankungen

Alarmins and their Role in Inflammatory Skin DiseasesY.  Dombrowski1 , S.  Koglin1 , T.  Ruzicka1 , J.  Schauber1
  • 1Klinik und Poliklinik für Dermatologie und Allergologie, Ludwig-Maximilians-Universität, München
Further Information

Publication History

Publication Date:
14 October 2010 (online)

Also available at
   Permissions and Reprints

Zusammenfassung

Körpereigene antimikrobielle Peptide (AMP) bilden einen Schutzfilm auf unserer Haut und schützen sie vor bakteriellen und viralen Infektionen. Neben ihrer Funktion in der Infektabwehr initiieren und koordinieren AMPs zudem die kutane Immunantwort und sind als sogenannte „Alarmine” ein wesentlicher Bestandteil des angeborenen Abwehrsystems. Entzündliche Hautkrankheiten, die mit einer Barrierestörung assoziiert sind, wie das atopische Ekzem, Psoriasis oder Rosazea, sind gekennzeichnet durch eine Fehlregulation des AMP Cathelicidin. Während bei der Rosazea eine fehlerhafte Proteinspaltung von Cathelicidin vorliegt, wird beim atopischen Ekzem eine verminderte Produktion diskutiert. Bei Psoriasis wiederum ist Cathelicidin erhöht und möglicherweise an einer Autoimmunreaktion beteiligt. Durch Eingriffe in die Expression von Cathelicidin und anderer AMP bietet sich vielleicht ein neuartiger therapeutischer Ansatz dieser Erkrankungen. Die Cathelicidinproduktion wird in der Haut über den Vitamin D3-Signalweg reguliert, was neue Therapiemöglichkeiten für entzündliche und infektiöse Hautkrankheiten eröffnen könnte. Bis dahin ist die Untersuchung der Regulationsmechanismen der AMPs Gegenstand intensiver dermatologischer Grundlagenforschung.

Abstract

Our skin is constantly exposed to potentially harmful microorganisms. As effectors of innate immunity antimicrobial peptides (AMP) protect the skin from bacterial or viral infections. Furthermore, these peptides are an essential part of the host's immune system as they initiate and coordinate immune reactions. Hence, the term „alarmins” has been coined to designate AMPs. Inflammatory skin diseases such as atopic eczema, rosacea and psoriasis are characterized by dysfunction or dysregulation of antimicrobial peptides. In rosacea, cathelicidin peptide processing is abnormal, whereas in atopic eczema the induction of cathelicidin may be diminished. In psoriasis cathelicidin expression is upregulated and may be involved in an autoimmune cascade. Pharmacological regulation of AMP expression could be a novel therapeutic strategy to ameliorate inflammation and hence the burden of these inflammatory diseases. Therefore, an in-depth understanding of molecular mechanisms underlying AMP regulation is needed and current subject of dermatological research.

Literatur

  • 1 Braff M H, Zaiou M, Fierer J et al. Keratinocyte production of cathelicidin provides direct activity against bacterial skin pathogens.  Infect Immun. 2005 Oct;  73 (10) 6771-6781
    CrossrefPubMedGoogle Scholar
  • 2 Agerberth B, Charo J, Werr J et al. The human antimicrobial and chemotactic peptides LL-37 and alpha-defensins are expressed by specific lymphocyte and monocyte populations.  Blood. 2000 Nov;  196 (9) 3086-3093
    PubMedGoogle Scholar
  • 3 Schauber J, Gallo R L. Expanding the roles of antimicrobial peptides in skin: alarming and arming keratinocytes.  J Invest Dermatol. 2007 Mar;  127 (3) 510-512
    CrossrefPubMedGoogle Scholar
  • 4 Harder J, Glaser R, Schroder J M. Human antimicrobial proteins effectors of innate immunity.  J Endotoxin Res. 2007;  13 (6) 317-338
    CrossrefPubMedGoogle Scholar
  • 5 Braff M H, Gallo R L. Antimicrobial peptides: an essential component of the skin defensive barrier.  Curr Top Microbiol Immunol. 2006;  306 91-110
    PubMedGoogle Scholar
  • 6 Cutuli M, Cristiani S, Lipton J M, Catania A. Antimicrobial effects of alpha-MSH peptides.  J Leukoc Biol. 2000 Feb;  67 (2) 233-239
    PubMedGoogle Scholar
  • 7 Schauber J, Gallo R L. Antimicrobial peptides and the skin immune defense system.  J Allergy Clin Immunol. 2008 Aug;  122 (2) 261-266
    CrossrefPubMedGoogle Scholar
  • 8 Peric M, Koglin S, Ruzicka T, Schauber J. [Cathelicidins: multifunctional defense molecules of the skin].  Dtsch Med Wochenschr. 2009 Jan;  134 (1 – 2) 35-38
    Article in Thieme ConnectPubMedGoogle Scholar
  • 9 Larrick J W, Lee J, Ma S et al. Structural, functional analysis and localization of the human CAP18 gene.  FEBS Lett. 1996 Nov 25;  398 (1) 74-80
    CrossrefPubMedGoogle Scholar
  • 10 Yamasaki K, Schauber J, Coda A et al. Kallikrein-mediated proteolysis regulates the antimicrobial effects of cathelicidins in skin.  FASEB J. 2006 Oct;  20 (12) 2068-2080
    CrossrefPubMedGoogle Scholar
  • 11 Zaiou M, Nizet V, Gallo R L. Antimicrobial and protease inhibitory functions of the human cathelicidin (hCAP18/LL-37) prosequence.  J Invest Dermatol. 2003;  120 (5) 810-816
    CrossrefPubMedGoogle Scholar
  • 12 Tokumaru S, Sayama K, Shirakata Y et al. Induction of keratinocyte migration via transactivation of the epidermal growth factor receptor by the antimicrobial peptide LL-37.  J Immunol. 2005 Oct 1;  175 (7) 4662-4668
    PubMedGoogle Scholar
  • 13 Di Nardo A, Braff M H, Taylor K R et al. Cathelicidin antimicrobial peptides block dendritic cell TLR4 activation and allergic contact sensitization.  J Immunol. 2007 Feb 1;  178 (3) 1829-1834
    PubMedGoogle Scholar
  • 14 Tomasinsig L, Pizzirani C, Skerlavaj B et al. The human cathelicidin LL-37 modulates the activities of the P2X7 receptor in a structure-dependent manner.  J Biol Chem. 2008 Nov 7;  283 (45) 30 471-30 481
    PubMedGoogle Scholar
  • 15 Ong P Y, Ohtake T, Brandt C et al. Endogenous antimicrobial peptides and skin infections in atopic dermatitis.  N Engl J Med. 2002 Oct 10;  347 (15) 1151-1160
    CrossrefPubMedGoogle Scholar
  • 16 Nomura I, Goleva E, Howell M D et al. Cytokine milieu of atopic dermatitis, as compared to psoriasis, skin prevents induction of innate immune response genes.  J Immunol. 2003;  171 (6) 3262-3269
    PubMedGoogle Scholar
  • 17 Ballardini N, Johansson C, Lilja G et al. Enhanced expression of the antimicrobial peptide LL-37 in lesional skin of adults with atopic eczema.  Br J Dermatol. 2009 Jul;  161 (1) 40-47
    PubMedGoogle Scholar
  • 18 Glaser R, Meyer-Hoffert U, Harder J et al. The antimicrobial protein psoriasin (S100A7) is upregulated in atopic dermatitis and after experimental skin barrier disruption.  J Invest Dermatol. 2009 Mar;  129 (3) 641-649
    CrossrefPubMedGoogle Scholar
  • 19 Harder J, Dressel S, Wittersheim M et al. Enhanced expression and secretion of antimicrobial peptides in atopic dermatitis and after superficial skin injury.  J Invest Dermatol. 2010 May;  130 (5) 1355-1364
    CrossrefPubMedGoogle Scholar
  • 20 Mallbris L, Carlen L, Wei T et al. Injury downregulates the expression of the human cathelicidin protein hCAP18/LL-37 in atopic dermatitis.  Exp Dermatol. 2010 May;  19 (5) 442-449
    CrossrefPubMedGoogle Scholar
  • 21 Yamasaki K, Di Nardo A, Bardan A et al. Increased serine protease activity and cathelicidin promotes skin inflammation in rosacea.  Nat Med. 2007 Aug;  13 (8) 975-980
    CrossrefPubMedGoogle Scholar
  • 22 Hollox E J, Huffmeier U, Zeeuwen P L et al. Psoriasis is associated with increased beta-defensin genomic copy number.  Nat Genet. 2008 Jan;  40 (1) 23-25
    CrossrefPubMedGoogle Scholar
  • 23 Henseler T, Christophers E. Disease concomitance in psoriasis.  J Am Acad Dermatol. 1995 Jun;  32 (6) 982-986
    CrossrefPubMedGoogle Scholar
  • 24 Lande R, Gregorio J, Facchinetti V et al. Plasmacytoid dendritic cells sense self-DNA coupled with antimicrobial peptide.  Nature. 2007 Oct 4;  449 (7162) 564-569
    CrossrefPubMedGoogle Scholar
  • 25 Wang T-T, Nestel F, Bourdeau V et al. Cutting Edge: 1,25-Dihydroxyvitamin D3 is a direct inducer of antimicrobial peptide gene expression.  J Immunol. 2004;  173 2909-2912
    PubMedGoogle Scholar
  • 26 Gombart A F, Saito T, Koeffler H P. Exaptation of an ancient Alu short interspersed element provides a highly conserved vitamin D-mediated innate immune response in humans and primates.  BMC Genomics. 2009;  10 321
    CrossrefPubMedGoogle Scholar
  • 27 Weber G, Heilborn J D, Chamorro Jimenez C I et al. Vitamin D induces the antimicrobial protein hCAP18 in human skin.  J Invest Dermatol. 2005 May;  124 (5) 1080-1082
    CrossrefPubMedGoogle Scholar
  • 28 Gombart A F, Borregaard N, Koeffler H P. Human cathelicidin antimicrobial peptide (CAMP) gene is a direct target of the vitamin D receptor and is strongly up-regulated in myeloid cells by 1,25-dihydroxyvitamin D3.  FASEB J. 2005 Jul;  19 (9) 1067-1077
    CrossrefPubMedGoogle Scholar
  • 29 Schauber J, Oda Y, Buchau A S et al. Histone acetylation in keratinocytes enables control of the expression of cathelicidin and CD14 by 1,25-Dihydroxyvitamin D(3).  J Invest Dermatol. 2008 April;  128 (4) 816-824
    CrossrefPubMedGoogle Scholar
  • 30 Dombrowski Y, Peric M, Koglin S et al. Control of cutaneous antimicrobial peptides by vitamin D3.  Arch Dermatol Res. 2010 Aug;  302 (6) 401-408
    CrossrefPubMedGoogle Scholar
  • 31 Glaser R, Navid F, Schuller W et al. UV-B radiation induces the expression of antimicrobial peptides in human keratinocytes in vitro and in vivo.  J Allergy Clin Immunol. 2009 May;  123 (5) 1117-1123
    CrossrefPubMedGoogle Scholar
  • 32 Vahavihu K, Ala-Houhala M, Peric M et al. Narrowband ultraviolet B treatment improves vitamin D balance and alters antimicrobial peptide expression in skin lesions of psoriasis and atopic dermatitis.  Br J Dermatol. 2010 Aug;  163 (2) 321-328
    CrossrefPubMedGoogle Scholar
  • 33 Peric M, Lehmann B, Vashina G et al. UV-B-triggered induction of vitamin D3 metabolism differentially affects antimicrobial peptide expression in keratinocytes.  J Allergy Clin Immunol. 2010 Mar;  125 (3) 746-749
    CrossrefPubMedGoogle Scholar
  • 34 Hata T R, Kotol P, Jackson M et al. Administration of oral vitamin D induces cathelicidin production in atopic individuals.  J Allergy Clin Immunol. 2008 Oct;  122 (4) 829-831
    CrossrefPubMedGoogle Scholar
  • 35 Jansen T, Krug S, Kind P et al. BsmI polymorphism of the vitamin D receptor gene in patients with the fulminant course of rosacea conglobata (rosacea fulminans).  J Dermatol. 2004 Mar;  31 (3) 244-246
    PubMedGoogle Scholar
  • 36 Rubin H. Serine protease inhibitors (SERPINS): where mechanism meets medicine.  Nat Med. 1996 Jun;  2 (6) 632-633
    CrossrefPubMedGoogle Scholar
  • 37 Uitto V J, Firth J D, Nip L, Golub L M. Doxycycline and chemically modified tetracyclines inhibit gelatinase A (MMP-2) gene expression in human skin keratinocytes.  Ann N Y Acad Sci. 1994 Sep 6;  732 140-151
    CrossrefPubMedGoogle Scholar
  • 38 Ganguly D, Chamilos G, Lande R et al. Self-RNA-antimicrobial peptide complexes activate human dendritic cells through TLR7 and TLR8.  J Exp Med. 2009 Aug 31;  206 (9) 1983-1994
    CrossrefPubMedGoogle Scholar
  • 39 Peric M, Koglin S, Dombrowski Y et al. Vitamin D analogs differentially control antimicrobial peptide/„alarmin”expression in psoriasis.  PLoS One. 2009;  4 (7) e6340
    CrossrefPubMedGoogle Scholar

Priv.-Doz. Dr. med. Jürgen Schauber

Klinik und Poliklinik für Dermatologie und Allergologie
Ludwig-Maximilians-Universität

Frauenlobstr. 9 – 11
80337 München

Email: juergen.schauber@med.uni-muenchen.de

      >